Long-term survival and outcomes after hospitalization for acute myocardial infarction complicated by cardiogenic shock

Clinical Cardiology

Volumn 32, Issue 8, 2009, Pages

  Drakos, Stavros G ^a   Bonios, Michael J ^a   Anastasiou Nana, Maria I ^a   Tsagalou, Eleftheria P ^a   Terrovitis, John V ^a   Kaldara, Elisabet ^a   Maroulidis, George ^a   Nanas, Serafim N ^a   Kanakakis, John ^a   Nanas, John N ^a,b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOPLASTY; AORTA BALLOON; ARTICLE; ARTIFICIAL VENTILATION; CARDIOGENIC SHOCK; CENTRAL VENOUS PRESSURE; CONTROLLED STUDY; COUNTERPULSATION; FEMALE; FOLLOW UP; HEART FAILURE; HEART MUSCLE REVASCULARIZATION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; POPULATION RESEARCH; SURVIVAL; SYSTOLIC BLOOD PRESSURE;

AGED; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMANS; INTRA-AORTIC BALLOON PUMPING; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; PATIENT DISCHARGE; RESPIRATION, ARTIFICIAL; RETROSPECTIVE STUDIES; SHOCK, CARDIOGENIC; SURVIVORS; THROMBOLYTIC THERAPY; TIME FACTORS; TREATMENT OUTCOME;

EID: 69249093476     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.20488     Document Type: Article

References (28)

1. Holmes DR Jr, Bates ER, Kleiman NS, et al. Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. The GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. J Am Coll Cardiol. 1995;26:668-674.
2. Sanborn TA, Feldman T. Management strategies for cardiogenic shock. Curr Opin Cardiol. 2004;19:608-612.
3. Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock?NEngl JMed. 1999;341: 625-634.
4. Holmes DR Jr, Califf RM, Van de Werf F, et al. Difference in countries' use of resources and clinical outcome for patients with cardiogenic shock after myocardial infarction: results from the GUSTO trial. Lancet. 1997;349:75-78.
5. The Trace Study Group. The TRAndolapril Cardiac Evaluation (TRACE) study: rationale, design, and baseline characteristics of the screened population. Am J Cardiol. 1994;73:44C-50C.
6. Duvernoy CS, Bates ER. Management of cardiogenic shock attributable to acute myocardial infarction in the reperfusion era. J Intensive Care Med. 2005;20:188-198. (Pubitemid 43093890)
7. Hochman JS, Sleeper LA, White HD, et al. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock? One-year survival following early revascularization for cardiogenic shock. JAMA. 2001;285:190-192.
8. Jacobs AK, Leopold JA, Bates E, et al. Cardiogenic shock caused by right ventricular infarction: a report from the SHOCK registry. J Am Coll Cardiol. 2003;41:1273-1279. (Pubitemid 36438986)
9. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2004;44:E201-E211.
10. Moulopoulos SD, Stamatelopoulos SF, Nanas JN, Kontoyannis DA, Nanas SN. Effect of protracted dobutamine infusion on survival of patients in cardiogenic shock treated with intra-aortic balloon pumping. Chest. 1993;103:248-252.
11. Babaev A, Frederick P, Pasta D, et al. NRMI Investigators: Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. JAMA. 2005;294:448-454. (Pubitemid 41124177)
12. Reynolds HR, Hochman JS. Cardiogenic shock current concepts and improving outcomes. Circulation. 2008;117:686-697.
13. Goldberg RJ, Samad NA, Yarzebski J, et al. NRMI Investigators: temporal trends in cardiogenic shock complicating acute myocardial infarction. N Engl JMed. 1999;340:1162-1168. (Pubitemid 29177875)
14. Hochman JS, Buller CE, Sleeper LA, et al. Cardiogenic shock complicating acute myocardial infarction-etiologies, management and outcome: a report from the SHOCK Trial Registry. Should we emergently revascularize occluded coronaries for cardiogenic shock? J Am Coll Cardiol. 2000;36:1063-1070.
15. Berger PB, Tuttle RH, Holmes DR Jr, et al. One-year survival among patients with acute myocardial infarction complicated by cardiogenic shock, and its relation to early revascularization. results from the GUSTO-I Trial. Circulation. 1999;99:873-878.
16. Bengtson JR, Kaplan AJ, Pieper KS, et al. Prognosis in cardiogenic shock after acute myocardial infarction in the interventional era. J Am Coll Cardiol. 1992;20:1482-1489.
17. Eltchaninoff H, Simpfendorfer C, Franco I, et al. Early and 1-year survival rates in acute myocardial infarction complicated by cardiogenic shock: a retrospective study comparing coronary angioplasty with medical treatment. Am Heart J. 1995;130:459-464.
18. Antoniucci D, Valenti R, Santoro G, et al. Systematic direct angioplasty and stent-supported direct angioplasty therapy for cardiogenic shock complicating acute myocardial infarction: in-hospital and long-term survival. J Am Coll Cardiol. 1998;31: 294-300. (Pubitemid 28153446)
19. Ammann P, Straumann E, Naegeli B, et al. Long-term results after acute percutaneus transluminal coronary angioplasty in acute myocardial infarction and cardiogenic shock. Int J Cardiol. 2002;82:127-131. (Pubitemid 34164389)
20. Hochman JS, Sleeper LA, Webb JG, et al. SHOCK Investigators: early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. JAMA. 2006;295:2511-2515. (Pubitemid 43854966)
21. Holmes DR Jr, Kip KE, Kelsey SF, Detre KM, Rosen AD. Cause of death analysis in the NHLBI PTCA Registry: results and considerations for evaluating long-term survival after coronary interventions. J Am Coll Cardiol. 1997;30:881-887.
22. Alter DA, Naylor CD, Austin PC, Tu JV. Long-term MI outcomes at hospitals with or without on-site revascularization. JAMA. 2001;285:2101-2108.
23. Sleeper LA, Jacobs AK, LeJemtel T, Webb JG, Hochman JS. A mortalitymodel and severity scoring system for cardiogenic shock complicating acute myocardial infarction [abstract]. Circulation. 2000;102:38-40.
24. Fincke R, Hochman JS, Lowe AM, et al. SHOCK Investigators: Cardiac power is the strongest hemodynamic correlate ofmortality in cardiogenic shock: a report from the SHOCK Trial Registry. J Am Coll Cardiol. 2004;44:340-348. (Pubitemid 38950593)
25. Singh M, White J, Hasdai D, et al. Long-term outcome and its predictors among patients with ST-segment elevation myocardial infarction complicated by shock: insights from the GUSTO-I trial. J Am Coll Cardiol. 2007;50:1752-1758. (Pubitemid 47600588)
26. Lim S, Jeong M, Bae E, et al. Predictive factors of major adverse cardiac events in acute myocardial infarction patients complicated by cardiogenic shock undergoing primary percutaneous coronary intervention. Circ J. 2005;69:154-158. (Pubitemid 40313033)
27. Brønnum-Hansen H, Jørgensen T, Davidsen M, et al. Survival and cause of death after myocardial infarction: the Danish MONICA study. J Clin Epidemiol. 2001;54:1244-1250. (Pubitemid 34002977)
28. Sleeper LA, Ramanathan K, Picard MH, et al. SHOCK Investigators: Functional status and quality of life after emergency revascularization for cardiogenic shock complicating acute myocardial infarction. J Am Coll Cardiol. 2005;46:266-273. (Pubitemid 40966854)